Expertise in
8
conditions

Alessandra Fabi

Rome, IT 
Expertise in
8
conditions
Rome, IT 

Overview

Alessandra Fabi practices practicing medicine in Rome, Italy.

Ms. Fabi is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Agranulocytosis, Mastectomy, and Vertebroplasty.

She is actively involved in clinical research, co-authoring 343 peer reviewed articles and participating in 4 clinical trials.

Gender

Female

Locations

Rome, Italy
Other Locations
Milan, 20133, Italy
Gravedona-san Gregorio, Italy
Bologna, Italy
Viterbo, 01100, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Double-blind, Placebo-controlled Adjuvant Trial in Newly Diagnosed Primary Glioblastoma Subjects to Assess the Efficacy and Safety of LAM561 in Combination With Radiotherapy and Temozolomide Standard of Care Treatment.
A Randomized, Double-blind, Placebo-controlled Adjuvant Trial in Newly Diagnosed Primary Glioblastoma Subjects to Assess the Efficacy and Safety of LAM561 in Combination With Radiotherapy and Temozolomide Standard of Care Treatment.
Enrollment Status: Active_not_recruiting
Publish Date: November 20, 2025
Intervention Type: Radiation, Drug
Study Drugs: 2-hydroxyoleic Acid, Temozolomide
Study Phase: Phase 2/Phase 3
Atezolizumab, Pertuzumab and Trastuzumab With Chemotherapy as Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer (APTneo)
Atezolizumab, Pertuzumab and Trastuzumab With Chemotherapy as Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer (APTneo)
Enrollment Status: Active_not_recruiting
Publish Date: March 06, 2024
Intervention Type: Drug, Procedure
Study Drugs: Trastuzumab, Pertuzumab, Carboplatin, Paclitaxel, Doxorubicin, Cyclophosphamide, Atezolizumab
Study Phase: Phase 3
A Phase II Trial of Atezolizumab Plus CArboplatin Plus Nab-paclitaxel as First-line Therapy in Metastatic Triple-negative PD-L1 Positive Breast Cancer Patients - the GIM25-CAPT Trial
A Phase II Trial of Atezolizumab Plus CArboplatin Plus Nab-paclitaxel as First-line Therapy in Metastatic Triple-negative PD-L1 Positive Breast Cancer Patients - the GIM25-CAPT Trial
Enrollment Status: Unknown
Publish Date: February 01, 2024
Intervention Type: Combination product
Study Drugs: Atezolizumab, Paclitaxel, Carboplatin
Study Phase: Phase 2
Multicenter, Randomized, Phase II Study of Neoadjuvant Chemotherapy Associated or Not With Zoledronate and Atorvastatin in Triple Negative Breast Cancers - YAPPETIZER Study
Multicenter, Randomized, Phase II Study of Neoadjuvant Chemotherapy Associated or Not With Zoledronate and Atorvastatin in Triple Negative Breast Cancers - YAPPETIZER Study
Enrollment Status: Completed
Publish Date: October 19, 2023
Intervention Type: Drug
Study Drugs: Zoledronate, Atorvastatin, Standard neoadjuvant chemotherapy
Study Phase: Phase 2
View 3 Less Clinical Trials

343 Total Publications

Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trial.
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trial.
Journal: Breast (Edinburgh, Scotland)
Published: May 12, 2026

Frequently Asked Questions about Alessandra Fabi

Is Alessandra Fabi a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Alessandra Fabi is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alessandra Fabi participate in research or clinical trials?

Yes. Alessandra Fabi has published 343 articles and abstracts on conditions like Breast Cancer. You can view a list of Alessandra Fabi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Fabi's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile